Invitrx was founded by Habib Torfi in 2003 following extensive research and clinical trials utilizing adult stem cell technology to treat patients suffering from burns, diabetic ulcers, ocular surface disorders, and other ophthalmic conditions. Today we’re widely regarded as one of the world’s leading stem cell technology companies.
Over the years our breakthrough technologies have become instrumental to the creation of numerous life-changing cell therapy products used in aesthetics, wound closure, plastic surgery, and reconstructive procedures. Invitrx has also developed and launched a consumer cosmetics line called Reluma, which features groundbreaking products that recapture the luminosity of youthful skin and hair.
Scientific Advisory Board
Distinguished Professor of Asia-Pacific Precision Medicine Vice President of Guangzhou Private Health Association President, Bergman Medical Group, Taiwan